arrow
C

Claudia Blattmann

university of stuttgart
H指数:20
被引数:2,989

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
2026-01-200
OAAI
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)

毛细血管扩张性骨肉瘤通过手术和化疗治疗:来自合作骨肉瘤研究组(COSS)的223例受影响患者报告

2025-09-090
OAAI
Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS

局部和转移性肺泡横纹肌肉瘤患者的预后因素。来自合作软组织肉瘤研究组CWS的两项研究和两个登记处的报告。

2025-01-090
OA
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial

trofosfamide,idarubicin和依托泊苷在横纹肌肉瘤和其他高危软组织肉瘤患者中的维持治疗 (CWS-2007-HR): 一项多中心,开放标签,随机对照3期试验

2024-12-010
OAAI
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma

RNA结合蛋白的系统分析确定骨肉瘤中的可靶向治疗脆弱性

2024-04-010
OAAI
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome

患有li-fraumeni综合征的儿童髓母细胞瘤患者的临床结果

2023-06-285
PRE
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)
2022-11-0111
PRE
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry
2022-08-168
OAAI
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
2021-07-149
OAAI
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
2021-07-0123
OAAI
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
2019-11-0127
OAAI